Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03304977
Other study ID # CACHACA
Secondary ID
Status Completed
Phase N/A
First received September 29, 2017
Last updated October 3, 2017
Start date June 6, 2016
Est. completion date October 30, 2016

Study information

Verified date September 2017
Source Groupe Hospitalier Paris Saint Joseph
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Oral antigoagulant are used more than 60 years in thrombotic diseases. Even they are indispensable, the haemorragic risk is high.That's why it's the main reason of hospitalization for iatrogeny.The complication's reasons are mainly linked to errors of drug intake, drugs interaction and the lack of understanding the treatment.Moreover, the antiplatelet agglutening treatment is frequently added to anticoagulant treatment.This increases the haemorragic risk.Different means were used to minimize the risk , like INR follow up.

The purpose of the study is to evaluate smartphone use to follow the patients'treatment.


Description:

Two questionnaire via smartphone with 15 days gap.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date October 30, 2016
Est. primary completion date July 31, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patient under ant-thrombotic treatment

- hospitalized in vascular medecine service

Exclusion Criteria:

- refusing the participation

Study Design


Intervention

Other:
questionnaire via smartphone
questionnaire via smartphone

Locations

Country Name City State
France Groupe Hospitalier Paris Saint Joseph Paris Ile-de-France

Sponsors (1)

Lead Sponsor Collaborator
Groupe Hospitalier Paris Saint Joseph

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary smartphone use level evaluation of the interest of patient to use their smartphone in the purpose to follow their anticoagulant treatment 15 days
See also
  Status Clinical Trial Phase
Completed NCT03826043 - THrombo-Embolic Event in Onco-hematology N/A
Recruiting NCT04274777 - The Relationship Between Lipid Peroxidation Products From Traumatic Brain Injury and Secondary Coagulation Disorders
Recruiting NCT03136510 - Evolution of Coagulation Activity in Non Valvular Atrial Fibrillation Patients Under Apixaban N/A
Completed NCT01588132 - Anfibatide Phase 1 Clinical Trial in Healthy Volunteers Phase 1
Recruiting NCT04488341 - Effect of Aerobic Exercises on Sex Hormones and Coagulation Factors in Postmenopausal Elderly Women N/A
Recruiting NCT04524637 - The Utility of Thromboelastography in Traumatic Brain Injury
Completed NCT03634215 - Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma
Completed NCT05152420 - Study of Intravenous VMX-C001 in Healthy Subjects and in Combination With Selected Direct Oral Anticoagulants in Healthy Older Subjects Phase 1
Recruiting NCT05645081 - Extracellular Vesicles and Dysregulated Coagulation in the Prediction of Stroke
Completed NCT04322721 - Coagulopathy on the First Postoperative Day Predicts the Long-term Survival of Traumatic Brain Injury Patients
Completed NCT03267823 - INR Comparison Testing in Cardiac Surgery
Completed NCT04490759 - QStat Pilot Reference Range Study
Completed NCT04107818 - Comparison of Viscoelastic Measurement by ROTEM® Delta and ClotPro® in Trauma Patients.
Recruiting NCT05484830 - Coagulation in Acute Aortic Dissection N/A
Recruiting NCT04111120 - Heparin Like Effect in Acute Variceal Bleeding
Completed NCT05162339 - Inflammatory Bowel Disease and Thromboembolic Events
Completed NCT03555630 - Thromboelastogram in Postdelivery Preeclamptic Patients
Completed NCT01589172 - Evaluating the Use of Thromboelastography to Diagnose Coagulopathy After Traumatic Brain Injury
Recruiting NCT04278404 - Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Completed NCT03956836 - Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)